ARCHIVES

NCI To Offer Expanded Access To Oxaliplatin

This article is from The Cancer Letter archive.

Vol. 28 No. 22 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Surgeon General Issues Call To Reduce Skin Cancer Rates

August 1, 2014

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999

Trial In Metastatic Disease To Be Unblinded After Regorafenib Meets Primary Endpoint

November 25, 2011

ONS Meeting Again With ASCO And AACR In San Francisco

April 28, 1989

ASCO Annual Meeting: New Regimens Promising For Metastatic Colon Cancer

July 28, 2006